Showing results (171-180 of 289) with videos related to
Sort By:
Pageof 29
The Journal of Endocrinology|October 1, 1989
Effects of growth hormone-releasing hormone on the secretion of islet hormones and on glucose homeostasis in lean and genetically obese-diabetic (ob/ob) mice and normal ratsC J Bailey, L C Wilkes, P R Flatt, et al.The Journal of the Royal College of General Practitioners|October 1, 1981
The economics of specialist and general practitioner maternity unitsA M Gray, R SteeleDiabetes Research (Edinburgh, Scotland)|February 1, 1989
Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic miceS K Swanston-Flatt, C Day, P R Flatt, et al.The Journal of Endocrinology|January 6, 2006
Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activityL Marenah, P R Flatt, D F Orr, et al.Regulatory Peptides|December 9, 2000
Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob miceF P O'Harte, M H Mooney, C M Kelly, et al.Chemico-Biological Interactions|January 1, 1988
Streptozotocin-induced diabetes modulates the metabolic activation of chemical carcinogensC Ioannides, S L Bass, A D Ayrton, et al.Peptides|March 16, 2024
MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetesE R Carr, P B Higgins, N H McClenaghan, et al.Health Policy (Amsterdam, Netherlands)|December 10, 1991
Forecasting the impact of demographic change: the case of the British National Health ServiceA M Gray, N BosanquetHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1987
Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in miceP R Flatt, C J Bailey, S M Hampton, et al.The Journal of Endocrinology|November 14, 2002
Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivoV A Gault, J C Parker, P Harriott, et al.Pageof 29